Global Blood Therapeutics, Inc. Operating Lease, Liability, Current
Global Blood Therapeutics, Inc. had Operating Lease, Liability, Current of $6.12 million as of 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2022-08-08
- 2022-06-30: Operating Lease, Liability, Current $6.12M.
- 2022-03-31: Operating Lease, Liability, Current $5.89M.
- 2021-12-31: Operating Lease, Liability, Current $5.67M.
- 2021-09-30: Operating Lease, Liability, Current $5.45M.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2022-06-30 | $6.12M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $5.89M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $5.67M 10-Q · filed 2022-08-08 |
| 2021-09-30 | $5.45M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $5.24M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $5.04M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $4.84M 10-K · filed 2022-02-23 |
| 2020-09-30 | $4.64M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $3.49M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $2.69M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $1.87M 10-K · filed 2021-02-24 |
| 2019-09-30 | $1.38M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $1.32M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $1.25M 10-Q · filed 2019-05-10 |